BridgeBio Pharma (BBIO) earnings

Earnings (net income) · fiscal 2025
-$724.93M

BridgeBio Pharma (BBIO) reported net income of -$724.93M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$535.76M. Figures as of 18 Nov 2026, 09:05 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$724.93M
Highest on record
-$43.83Mfiscal 2017
Lowest on record
-$724.93Mfiscal 2025
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BridgeBio Pharma earnings, in more detail

Across the 9 fiscal years on record (2017–2025), the highest was -$43.83M in fiscal 2017 and the lowest -$724.93M in fiscal 2025.

History · 9 fiscal years

Earnings (net income) by fiscal year

BridgeBio Pharma earnings, year by year

BridgeBio Pharma (BBIO) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$724.93M—
2024-$535.76M—
2023-$643.20M—
2022-$481.18M—
2021-$586.45M—
2020-$505.49M—
2019-$288.59M—
2018-$169.45M—
2017-$43.83M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of BridgeBio Pharma and comparable companies
CompanyEarnings (net income)Fiscal year
ICON ICLR$229.34M2025
Jazz Pharmaceuticals JAZZ-$356.15M2025
Solventum SOLV$1.56B2025
BridgeBio Pharma BBIO-$724.93M2025
Summit Therapeutics SMMT-$1.08B2025
Glaukos GKOS-$187.69M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma earnings: questions and answers

What is BridgeBio Pharma's net income?

BridgeBio Pharma (BBIO) reported net income of -$724.93M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$535.76M.

What are the highest and lowest net income figures on record for BridgeBio Pharma?

Across the 9 fiscal years on record (2017–2025), the highest was -$43.83M in fiscal 2017 and the lowest -$724.93M in fiscal 2025.

How is BridgeBio Pharma's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For BridgeBio Pharma it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.